Share Your Comments and Experiences in Support of Extending HPV Vaccine Coverage to U.S. Boys and Young Men

The number of people who are able to receive the HPV (Human Papillomavirus) vaccine Gardasil may be about to double. But will the number of people who can afford to get it follow suit?

Gardasil was approved by the U.S. Food and Drug Administration (FDA) in 2006, and as of September 2009 it was indicated for girls and women between the ages of 9 and 26. It protects people from becoming infected with four types of human papillomavirus (HPV), two of which are responsible for about 70 percent of cervical cancers worldwide.

But, according to recent research, Gardasil seems to be effective in males as well; it appears to help prevent genital warts, as well as anal cancer, penile cancer and other types of cancers that are potentially caused by HPV.

However, FDA approval is not the end of the road. Next up are hearings at the U.S. Centers for Disease Control and Prevention (CDC) over whether the federal government should pay for boys and young men to receive this vaccine through government-funded health programs like Medicaid and Veterans Affairs. These hearings will take place Wednesday, Oct. 21, and Thursday, Oct. 22.

You can do your part to help make sure this vaccine will be available to as many boys and young men as possible. AIDS Treatment Activists Coalition (ATAC) is trying to get as many men as it can who have experienced, or lost partners to, anal or penile cancers to consider testifying as to the importance of this vaccine. Here's how you can join the effort:

1. Attend the hearings in Atlanta. People wishing to attend should register for the hearing online by Friday, Oct. 2, if they're not citizens of the U.S.; and by Friday, Oct. 9, if they are U.S. citizens. In addition, Jeff Taylor of the AIDS Treatment Activists Coalition, an anal cancer survivor who also plans to attend the hearings, has requested you e-mail him directly at rolyatffej@aol.com if you're going to go the hearing on Oct. 21.
2. E-mail your thoughts. If you can't make it to Atlanta and would still like to submit your comments about extending federal coverage of Gardasil's to include boys and young men, e-mail your comments by Wednesday, Oct. 21, to the Advisory Committee on Immunization Practices (ACIP) at acip@cdc.gov.

Your comments can make a difference! At a similar hearing regarding recommendations for Gardasil when the indication was expanded to include young women as well as girls, the public testimony and comments helped convince the hearing committee to recommend federal coverage of Gardasil for young women.